Gucagonoma syndrome is an underdiagnosed clinical entity

James A. Edney, Scott Hofmann, Jon S. Thompson, Anne Kessinger

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Glucagonomas, considered among the rarest of the islet cell neoplasms, produce a well-defined clinical syndrome characterized by necrolytic migratory erythema, diabetes mellitus, glossitis, anemia, and weight loss. This report describes seven patients with glucagonoma treated at our institution. All seven had the characteristic dermatologic manifestations, present from 1 to 6 years prior to diagnosis. Five patients had extensive disease at the time of initial operation, three of whom underwent aggressive cytoreductive surgery, whereas the other two had biopsy only. The remaining two patients presented with a single nodule each, underwent distal pancreatectomy and splenectomy, and remain free of disease 2 and 6 years postoperatively. Earlier recognition of the distinctive physical findings peculiar to this syndrome should increase survival. Aggressive cytoreductive surgery results in prolonged remission.

Original languageEnglish (US)
Pages (from-to)625-629
Number of pages5
JournalThe American Journal of Surgery
Volume160
Issue number6
DOIs
StatePublished - Dec 1990

Fingerprint

Glucagonoma
Necrolytic Migratory Erythema
Glossitis
Pancreatectomy
Splenectomy
Islets of Langerhans
Anemia
Weight Loss
Diabetes Mellitus
Biopsy
Survival
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Gucagonoma syndrome is an underdiagnosed clinical entity. / Edney, James A.; Hofmann, Scott; Thompson, Jon S.; Kessinger, Anne.

In: The American Journal of Surgery, Vol. 160, No. 6, 12.1990, p. 625-629.

Research output: Contribution to journalArticle

@article{1709a446e27144c386c1c7def15a393e,
title = "Gucagonoma syndrome is an underdiagnosed clinical entity",
abstract = "Glucagonomas, considered among the rarest of the islet cell neoplasms, produce a well-defined clinical syndrome characterized by necrolytic migratory erythema, diabetes mellitus, glossitis, anemia, and weight loss. This report describes seven patients with glucagonoma treated at our institution. All seven had the characteristic dermatologic manifestations, present from 1 to 6 years prior to diagnosis. Five patients had extensive disease at the time of initial operation, three of whom underwent aggressive cytoreductive surgery, whereas the other two had biopsy only. The remaining two patients presented with a single nodule each, underwent distal pancreatectomy and splenectomy, and remain free of disease 2 and 6 years postoperatively. Earlier recognition of the distinctive physical findings peculiar to this syndrome should increase survival. Aggressive cytoreductive surgery results in prolonged remission.",
author = "Edney, {James A.} and Scott Hofmann and Thompson, {Jon S.} and Anne Kessinger",
year = "1990",
month = "12",
doi = "10.1016/S0002-9610(05)80761-5",
language = "English (US)",
volume = "160",
pages = "625--629",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Gucagonoma syndrome is an underdiagnosed clinical entity

AU - Edney, James A.

AU - Hofmann, Scott

AU - Thompson, Jon S.

AU - Kessinger, Anne

PY - 1990/12

Y1 - 1990/12

N2 - Glucagonomas, considered among the rarest of the islet cell neoplasms, produce a well-defined clinical syndrome characterized by necrolytic migratory erythema, diabetes mellitus, glossitis, anemia, and weight loss. This report describes seven patients with glucagonoma treated at our institution. All seven had the characteristic dermatologic manifestations, present from 1 to 6 years prior to diagnosis. Five patients had extensive disease at the time of initial operation, three of whom underwent aggressive cytoreductive surgery, whereas the other two had biopsy only. The remaining two patients presented with a single nodule each, underwent distal pancreatectomy and splenectomy, and remain free of disease 2 and 6 years postoperatively. Earlier recognition of the distinctive physical findings peculiar to this syndrome should increase survival. Aggressive cytoreductive surgery results in prolonged remission.

AB - Glucagonomas, considered among the rarest of the islet cell neoplasms, produce a well-defined clinical syndrome characterized by necrolytic migratory erythema, diabetes mellitus, glossitis, anemia, and weight loss. This report describes seven patients with glucagonoma treated at our institution. All seven had the characteristic dermatologic manifestations, present from 1 to 6 years prior to diagnosis. Five patients had extensive disease at the time of initial operation, three of whom underwent aggressive cytoreductive surgery, whereas the other two had biopsy only. The remaining two patients presented with a single nodule each, underwent distal pancreatectomy and splenectomy, and remain free of disease 2 and 6 years postoperatively. Earlier recognition of the distinctive physical findings peculiar to this syndrome should increase survival. Aggressive cytoreductive surgery results in prolonged remission.

UR - http://www.scopus.com/inward/record.url?scp=0025602750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025602750&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(05)80761-5

DO - 10.1016/S0002-9610(05)80761-5

M3 - Article

C2 - 2252125

AN - SCOPUS:0025602750

VL - 160

SP - 625

EP - 629

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -